Rockwell Medical (RMTI) Competitors $2.22 +0.21 (+10.45%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RMTI vs. ARAY, RSLS, ABT, ISRG, SYK, BSX, MDT, BDX, EW, and IDXXShould you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Accuray (ARAY), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), and IDEXX Laboratories (IDXX). These companies are all part of the "health care equipment" industry. Rockwell Medical vs. Accuray ReShape Lifesciences Abbott Laboratories Intuitive Surgical Stryker Boston Scientific Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories Accuray (NASDAQ:ARAY) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Is ARAY or RMTI more profitable? Rockwell Medical has a net margin of -1.25% compared to Accuray's net margin of -3.72%. Rockwell Medical's return on equity of 8.55% beat Accuray's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-3.72% -36.93% -3.52% Rockwell Medical -1.25%8.55%3.80% Do analysts rate ARAY or RMTI? Accuray currently has a consensus target price of $9.00, indicating a potential upside of 371.20%. Rockwell Medical has a consensus target price of $6.00, indicating a potential upside of 170.27%. Given Accuray's higher possible upside, research analysts clearly believe Accuray is more favorable than Rockwell Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk & volatility, ARAY or RMTI? Accuray has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Rockwell Medical has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Does the media favor ARAY or RMTI? In the previous week, Rockwell Medical had 12 more articles in the media than Accuray. MarketBeat recorded 12 mentions for Rockwell Medical and 0 mentions for Accuray. Accuray's average media sentiment score of 1.29 beat Rockwell Medical's score of 0.34 indicating that Accuray is being referred to more favorably in the media. Company Overall Sentiment Accuray Positive Rockwell Medical Neutral Does the MarketBeat Community prefer ARAY or RMTI? Accuray received 22 more outperform votes than Rockwell Medical when rated by MarketBeat users. Likewise, 65.61% of users gave Accuray an outperform vote while only 57.73% of users gave Rockwell Medical an outperform vote. CompanyUnderperformOutperformAccurayOutperform Votes33265.61% Underperform Votes17434.39% Rockwell MedicalOutperform Votes31057.73% Underperform Votes22742.27% Do institutionals & insiders believe in ARAY or RMTI? 64.1% of Accuray shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 4.2% of Accuray shares are held by company insiders. Comparatively, 1.9% of Rockwell Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, ARAY or RMTI? Rockwell Medical has lower revenue, but higher earnings than Accuray. Rockwell Medical is trading at a lower price-to-earnings ratio than Accuray, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$444.20M0.43-$15.55M-$0.17-11.24Rockwell Medical$98.92M0.73-$8.44M-$0.05-44.40 SummaryAccuray and Rockwell Medical tied by winning 9 of the 18 factors compared between the two stocks. Ad Porter & CompanyHiding in the Bible New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.This is the untold, true story of God’s Investment. Get Rockwell Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RMTI vs. The Competition Export to ExcelMetricRockwell MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.75M$6.87B$5.20B$9.31BDividend YieldN/A3.06%4.80%4.06%P/E Ratio-44.4010.75128.1117.53Price / Sales0.73287.461,260.62139.54Price / Cash105.1056.6541.3637.95Price / Book2.965.394.894.92Net Income-$8.44M$152.04M$119.92M$225.78M7 Day Performance8.82%-4.33%16.64%-1.56%1 Month Performance-5.53%2.79%16.35%6.68%1 Year Performance31.36%17.30%35.47%22.48% Rockwell Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RMTIRockwell Medical4.2725 of 5 stars$2.22+10.4%$6.00+170.3%+27.2%$71.75M$98.92M-44.40300News CoverageGap UpHigh Trading VolumeARAYAccuray4.657 of 5 stars$1.97+2.6%$9.00+356.9%-28.5%$198.11M$444.20M-11.29987Positive NewsRSLSReShape Lifesciences1.1389 of 5 stars$4.66-1.3%N/A-76.1%$3.32M$8.18M0.0050Positive NewsGap UpABTAbbott Laboratories4.9335 of 5 stars$113.62+0.2%$130.71+15.0%+5.6%$197.07B$41.22B34.46114,000Dividend IncreaseShort Interest ↑ISRGIntuitive Surgical4.7706 of 5 stars$546.88+1.4%$550.28+0.6%+68.1%$194.79B$7.87B86.7513,676Positive NewsSYKStryker4.9182 of 5 stars$374.12-0.1%$404.35+8.1%+27.8%$142.62B$20.50B40.1552,000Dividend IncreasePositive NewsBSXBoston Scientific4.5351 of 5 stars$90.97+1.0%$94.43+3.8%+62.0%$134.07B$15.91B75.0248,000Analyst ForecastShort Interest ↑MDTMedtronic4.9709 of 5 stars$82.06-0.5%$95.27+16.1%-1.5%$105.22B$33.00B25.1495,000Options VolumePositive NewsBDXBecton, Dickinson and Company4.9806 of 5 stars$229.70+1.8%$283.50+23.4%-4.8%$66.41B$20.18B37.9774,000Short Interest ↓EWEdwards Lifesciences3.9972 of 5 stars$73.37+0.1%$79.40+8.2%-3.6%$43.27B$6.00B10.7419,800Analyst UpgradeInsider TradeAnalyst RevisionIDXXIDEXX Laboratories4.991 of 5 stars$434.57+0.6%$539.63+24.2%-21.1%$35.58B$3.84B41.6711,000Positive News Related Companies and Tools Related Companies Accuray Alternatives ReShape Lifesciences Alternatives Abbott Laboratories Alternatives Intuitive Surgical Alternatives Stryker Alternatives Boston Scientific Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RMTI) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rockwell Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rockwell Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
